1. Home
  2. FAMI vs TTNP Comparison

FAMI vs TTNP Comparison

Compare FAMI & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAMI
  • TTNP
  • Stock Information
  • Founded
  • FAMI 2015
  • TTNP 1991
  • Country
  • FAMI China
  • TTNP United States
  • Employees
  • FAMI N/A
  • TTNP N/A
  • Industry
  • FAMI Packaged Foods
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FAMI Consumer Staples
  • TTNP Health Care
  • Exchange
  • FAMI Nasdaq
  • TTNP Nasdaq
  • Market Cap
  • FAMI 3.1M
  • TTNP 3.0M
  • IPO Year
  • FAMI 2018
  • TTNP 1996
  • Fundamental
  • Price
  • FAMI $0.24
  • TTNP $3.25
  • Analyst Decision
  • FAMI
  • TTNP
  • Analyst Count
  • FAMI 0
  • TTNP 0
  • Target Price
  • FAMI N/A
  • TTNP N/A
  • AVG Volume (30 Days)
  • FAMI 5.6M
  • TTNP 36.8K
  • Earning Date
  • FAMI 02-14-2025
  • TTNP 03-31-2025
  • Dividend Yield
  • FAMI N/A
  • TTNP N/A
  • EPS Growth
  • FAMI N/A
  • TTNP N/A
  • EPS
  • FAMI N/A
  • TTNP N/A
  • Revenue
  • FAMI $64,131,332.00
  • TTNP N/A
  • Revenue This Year
  • FAMI N/A
  • TTNP N/A
  • Revenue Next Year
  • FAMI N/A
  • TTNP N/A
  • P/E Ratio
  • FAMI N/A
  • TTNP N/A
  • Revenue Growth
  • FAMI N/A
  • TTNP N/A
  • 52 Week Low
  • FAMI $0.17
  • TTNP $3.03
  • 52 Week High
  • FAMI $2.35
  • TTNP $14.80
  • Technical
  • Relative Strength Index (RSI)
  • FAMI 37.45
  • TTNP 46.75
  • Support Level
  • FAMI $0.29
  • TTNP $3.17
  • Resistance Level
  • FAMI $0.27
  • TTNP $3.50
  • Average True Range (ATR)
  • FAMI 0.04
  • TTNP 0.32
  • MACD
  • FAMI -0.01
  • TTNP -0.01
  • Stochastic Oscillator
  • FAMI 6.10
  • TTNP 19.32

About FAMI Farmmi Inc.

Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Share on Social Networks: